68
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer

, , , , &
Pages 1969-1975 | Published online: 11 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giorgio Mustacchi & Michelino De Laurentiis. (2015) The role of taxanes in triple-negative breast cancer: literature review. Drug Design, Development and Therapy 9, pages 4303-4318.
Read now

Articles from other publishers (3)

Fengchang Zhu, Chengyin Liu, Huaji Zhang & Liping Bai. (2022) Efficacy and Safety of Albumin-bound Paclitaxel Versus Solvent-based Paclitaxel in Breast Cancer: A Meta-analysis. Journal of Modern Nanotechnology 2:1.
Crossref
Yifan Xie, Siyu Wu, Ying Zhang, Jianwei Li, Miao Mo, Zhimin Shao & Guangyu Liu. (2021) Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer. Frontiers in Oncology 11.
Crossref
Yu Zong, Jiayi Wu & Kunwei Shen. (2017) Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis. Oncotarget 8:10, pages 17360-17372.
Crossref